Endoscopic Devices - Netherlands | Statista Market Forecast

In the Netherlands, revenue in the Endoscopic Devices market market is projected to reach US$317.40m in 2024.
The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 7.22%, leading to a market volume of US$449.70m by 2029.
When compared globally, the highest revenue will be generated the United States, with an expected figure of US$10.39bn in 2024.
The Netherlands is experiencing a robust integration of advanced endoscopic devices within its healthcare system, enhancing minimally invasive surgical procedures and patient outcomes.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in the Netherlands is experiencing moderate growth, influenced by factors such as advancements in minimally invasive procedures, increasing demand for early diagnosis, and enhanced healthcare infrastructure supporting innovative medical technologies.

Customer preferences: Consumers in the Netherlands are showing a growing preference for minimally invasive surgical options, reflecting a cultural shift towards prioritizing quicker recovery times and less postoperative discomfort. This trend is influenced by an aging population that values efficient healthcare solutions. Additionally, there is an increasing awareness around preventive healthcare, prompting individuals to seek early diagnostic procedures facilitated by advanced endoscopic devices. As health literacy improves, patients are more engaged in their treatment choices, steering demand towards innovative technologies that enhance safety and efficacy.

Trends in the market: In the Netherlands, the Endoscopic Devices Market is experiencing a notable shift towards advanced imaging technologies and robotic-assisted procedures, enhancing precision in minimally invasive surgeries. This transition is driven by patient demand for quicker recovery and reduced hospital stays, especially among the aging population. Additionally, the rise of preventive healthcare initiatives is encouraging earlier diagnoses, increasing the utilization of endoscopic tools. For industry stakeholders, these trends underscore the importance of investing in innovative technologies and training to meet evolving patient needs and improve surgical outcomes.

Local special circumstances: In the Netherlands, the Endoscopic Devices Market is influenced by a robust healthcare system characterized by high standards and strict regulatory frameworks. The country's emphasis on patient-centered care fosters a culture prioritizing minimally invasive procedures, aligning with the increasing demand for quicker recovery times. Additionally, the strong presence of innovative healthcare research institutions and partnerships with technology firms facilitates rapid advancements in imaging and robotic-assisted technologies. These local dynamics enhance the market's growth potential and drive the adoption of cutting-edge endoscopic solutions.

Underlying macroeconomic factors: The Endoscopic Devices Market in the Netherlands is shaped by significant macroeconomic factors, including the nation’s stable economic growth, high healthcare expenditure, and a strong emphasis on innovation. The Dutch government’s fiscal policies support healthcare advancements, promoting investment in medical technologies. Furthermore, the increasing prevalence of chronic diseases and an aging population drive demand for minimally invasive procedures, aligning with global trends towards improved patient outcomes. Additionally, favorable trade agreements and collaboration with international medical technology firms enhance market competitiveness, facilitating the adoption of advanced endoscopic solutions within the healthcare system.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.